Pills for COVID-19
…to block SARS-CoV-2 transmission in ferrets. Interim results in 775 patients of a phase 3 clinical trial with molnupiravir show that the drug reduced hospitalization or death about 50% compared…
…to block SARS-CoV-2 transmission in ferrets. Interim results in 775 patients of a phase 3 clinical trial with molnupiravir show that the drug reduced hospitalization or death about 50% compared…
…how they are tested in clinical trials. [powerpress url=”http://traffic.libsyn.com/twiv/TWiV052.mp3″] Click the arrow above to play, or right-click to download TWiV #52 (51 MB .mp3, 71 minutes) Subscribe to TWiV in…
…accident, deliberate release, or a vaccine trial. Rozo and Gronvall have re-examined the available evidence for the origin of the 1977 H1N1 virus. While there is ample documentation of the…
…in an infected individual appear to be nonviable, suggesting that the population exists at its error threshold. What would happen if we could push replicating genomes over the error threshold?…
…molecules that catalysed their own synthesis. Viroids have properties that make them candidates for survivors of the RNA world: small genome size (to avoid error catastrophe caused by error-prone replication),…
…This property is useful for controlling outbreaks in communities and institutions. Daiichi Sankyo Co. started a Phase III trial for adults and a pediatric Phase II/III trial with CS-8958 in…